Mirati Therapeutics, Inc., a commercial stage biotechnology company, announced the Journal of Clinical Oncology published in a Rapid Communication data indicating adagrasib, a potent and selective...
Onco360, the nation’s leading independent Specialty Pharmacy, has been selected by Mirati Therapeutics to be a specialty pharmacy partner for KRAZATI, which is an...
